Symrise posts 2008 results
This article was originally published in The Rose Sheet
Executive Summary
U.S. acquisitions help boost sales for the fragrance and flavors firm by 25% to roughly $1.65 bil. in fiscal 2008, Symrise announces March 4. Firm bought Intercontinental Fragrances and Manheimer Fragrances in October (1"The Rose Sheet" Oct. 6, 2008, p. 10). Net of acquisitions, sales increased by 3.5% in local currencies. Symrise says it made "additional progress" by tapping the sales potential of large multinational customers and fast-growing emerging markets. Sales in emerging markets grew by 8% and claimed 39% of total sales in 2008, firm notes. Sales for firm's Scent & Care division were roughly even with 2007, at approximately $842.4 mil. for the year. Economic crisis is likely to produce a weaker first half of 2009 as compared with the prior-year period, but Symrise expects to grow faster than the market. "Despite the challenging business environment, we consider our core business to be as stable and robust as ever," CEO Gerold Linzbach says
You may also be interested in...
Symrise Continues To Grow Business, Buying Two Air-Care Scent Developers
Symrise acquires Intercontinental Fragrances and Manheimer Fragrances - increasing its stake in the $300 million North American air-care market - in its latest play for a bigger slice of the global flavors and fragrances pie
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.